Loading...

Specifications of a continual reassessment method design for phase I trials of combined drugs()

In studies of combinations of agents in phase I oncology trials, the dose–toxicity relationship may not be monotone for all combinations, in which case the toxicity probabilities follow a partial order. The continual reassessment method for partial orders (PO-CRM) is a design for phase I trials of c...

Full description

Saved in:
Bibliographic Details
Main Authors: Wages, Nolan A., Conaway, Mark R.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3771354/
https://ncbi.nlm.nih.gov/pubmed/23729323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1575
Tags: Add Tag
No Tags, Be the first to tag this record!